MedTrace Logo

Evaluation of Celsior® in Liver Transplant Preservation.

NCT00151593 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2007-11-26

No results posted yet for this study

Summary

The aim of the study is to determine the efficacy and safety of a preservation solution in liver transplantation. Its efficacy will be compared to the efficacy of other currently used preservation solutions.

Conditions

  • Liver Transplantation

Interventions

OTHER

Celsior®

Graft preservation solution

Sponsors & Collaborators

  • Sangstat Medical Corporation

    collaborator INDUSTRY

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Karim Boudjema, MD, PhD · CHU Rennes

  • Eric Bellissant, MD, PhD · CHU Rennes

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-02-28
Completion
2006-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00151593 on ClinicalTrials.gov